1-3 of 3
Pierre Gestraud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Open Access
Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, Barbara Martins Da Costa, Karen Barker, Sumana Shrestha, J. Ciaran Hutchinson, Simran Dhariwal, Angharad Goodman, Elaine Del Nery, Pierre Gestraud, Jaydutt Bhalshankar, Yasmine Iddir, Elnaz Saberi-Ansari, Alexandra Saint-Charles, Birgit Geoerger, Maria Eugénia Marques Da Costa, Cécile Pierre-Eugène, Isabelle Janoueix-Lerosey, Didier Decaudin, Fariba Nemati, Angel M. Carcaboso, Didier Surdez, Olivier Delattre, Sally L. George, Louis Chesler, Deborah A. Tweddle, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1317–1331.
https://doi.org/10.1158/1078-0432.CCR-22-2274
Published: 03 April 2023
View articletitled, Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Open the PDF for Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models in another window
Includes: Supplementary data
Journal Articles

Abstract A43: Centrosome amplification favors survival and impairs ovarian cancer progression

Free
Jean-Philippe Morretton, Aurelie Herbette, Camille Cosson, Bassirou Mboup, Aurelien Latouche, Pierre Gestraud, Tatiana Popova, Marc-Henri Stern, Fariba Nemati, Didier Decaudin, Guillaume Bataillon, Veronique Becette, Didier Meseure, Andre Nicolas, Odette Mariani, Claire Bonneau, Jorge Barbazan, Anne Vincent-Salomon, Fatima Mechta-Grigoriou, Sergio Roman-Roman, Roman Rouzier, Xavier Sastre-Garau, Oumou Goundiam, Renata Basto
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A43.
https://doi.org/10.1158/1557-3265.OVCA19-A43
Published: 01 July 2020
View articletitled, Abstract A43: Centrosome amplification favors survival and impairs ovarian cancer progression
Journal Articles

Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target

Free
Thomas Grellety, Celine Callens, Elodie Richard, Adrien Briaux, Valérie Vélasco, Marina Pulido, Anthony Gonçalves, Pierre Gestraud, Gaetan MacGrogan, Hervé Bonnefoi, Bruno Cardinaud
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (2): 856–867.
https://doi.org/10.1158/1078-0432.CCR-18-1469
Published: 15 January 2019
View articletitled, Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
Open the PDF for Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target in another window
Includes: Supplementary data